ReviewCurrent treatment options in oncology2020

Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors.

Subashini Sharon Gnanendran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.